https://scholars.lib.ntu.edu.tw/handle/123456789/617127
標題: | Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYnote-028 study | 作者: | CHIUN HSU Lee S.-H. Ejadi S. Even C. Cohen R.B. Le Tourneau C. Mehnert J.M. Algazi A. Van Brummelen E.M.J. Saraf S. Thanigaimani P. Cheng J.D. Hansen A.R. |
公開日期: | 2017 | 出版社: | American Society of Clinical Oncology | 卷: | 35 | 期: | 36 | 起(迄)頁: | 4050-4056 | 來源出版物: | Journal of Clinical Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038381568&doi=10.1200%2fJCO.2017.73.3675&partnerID=40&md5=09e578575720d1ccbf01b0279ac8a172 https://scholars.lib.ntu.edu.tw/handle/123456789/617127 |
ISSN: | 0732-183X | DOI: | 10.1200/JCO.2017.73.3675 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。